BEUDAMED
    FDA Adverse Event Injury Summary report: N

    SELOX ST 60

    MDR report key: 3211823 · Received July 8, 2013

    Report

    Report Number
    1028232-2013-01864
    Event Type
    Injury
    Date Received
    July 8, 2013
    Date of Event
    May 13, 2013
    Report Date
    June 27, 2013
    Manufacturer
    BIOTRONIK SE & CO. KG
    Product Code
    NVN
    PMA / PMN Number
    P950037
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    GM
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 1

    THE LEAD UNDER COMPLAINT WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE BASED ON THE INSPECTION OF THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR LEAD AS WELL AS THE HOME MONITORING DATA RETURNED FOR ANALYSIS. THE MANUFACTURING PROCESS FOR THIS LEAD WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING PROCESS WHICH MIGHT BE RELATED TO THE CLINICAL OBSERVATION. THE RETURNED DATA WERE ANALYZED. THE INSPECTION REVEALED A SLOWLY INCREASING VENTRICULAR PACING IMPEDANCE WITH VALUES UP TO > 2000 OHM, AS INDICATED IN THE COMPLAINT DESCRIPTION. IN SUMMARY, THE LEAD WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION AVAILABLE FOR ANALYSIS, NO CONCLUSIONS CAN BE DRAWN REGARDING THE ROOT CAUSE OF THE CLINICAL OBSERVATION. THE REVIEW OF THE QUALITY DOCUMENTS CONFIRMED A REGULAR LEAD MANUFACTURING.

    Description of Event or Problem · 1

    OUS MDR - SLOWLY INCREASING VENTRICULAR IMPEDANCE (>2000 OHMS) LEADING TO EXIT BLOCK WERE REPORTED BY HOME MONITORING AND CONFIRMED DURING A FOLLOW-UP. THE EXPLANTATION OF THE LEAD IS PLANNED. THIS IS ALL OF THE AVAILABLE INFORMATION AT THIS TIME. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS EVENT WILL BE UPDATED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    309077 SELOX ST 60 PACER LEAD NVN BIOTRONIK SE & CO. KG 346367

    Patients

    Seq Age Sex Outcome Treatment
    1 Other